Strategic Focus on AI Drug Development and Advanced Medical Devices

Joint Management of Research Data... 2 Trillion Won R&D Investment Planned by 2030

The government will select and strategically foster the “Top 30 National Healthcare Technologies” to strengthen the global competitiveness of the biohealth sector. By focusing support on future core technologies such as AI-based drug development, advanced medical devices, and regenerative medicine, as well as building a joint research data management system, the government also aims to strengthen the data-utilization foundation needed for the era of AI-driven healthcare.


Selection of Top 30 National Healthcare Technologies... Securing a Technological Edge in Biohealth View original image

The Ministry of Health and Welfare announced on July 23 at the Lotte Hotel in Seoul that it held the “2nd Healthcare Technology Policy Deliberation Committee Meeting of 2026,” where it discussed matters including the establishment of the Joint Management Regulation for research data from healthcare R&D projects, the selection plan for the Top 30 National Healthcare Technologies, and directions for R&D investment in healthcare for 2027.


First, the Ministry and the Korea Health Industry Development Institute are working to select the “Top 30 National Healthcare Technologies” to address future societal changes and secure a significant technological lead in the healthcare industry. The plan is to discover strategic technologies that can simultaneously resolve major national healthcare challenges and lead the global market, providing full-cycle support from research and development to commercialization. These core technologies will be selected across four categories: market-creating, technology breakthrough, field issue, and challenge-solving. The final selection will be confirmed in September after comprehensively reviewing technology demand and future issues.


The system for research data utilization will also be significantly revised. The Ministry of Health and Welfare and the Korea Disease Control and Prevention Agency will establish a joint management regulation that requires research data generated from national R&D projects to be deposited and registered with the Healthcare R&D Information Center (CODA). Data produced during the project execution process will be managed systematically. The principle will be de-identification and granting of minimum access rights to ensure both the protection of personal information and enhanced security.


Alongside these efforts, the government plans to increase the healthcare R&D budget for relevant ministries to 2 trillion won by 2030. The aim is to become one of the world’s top 5 biohealth powers and raise technology levels to 85% of the world’s leading countries. The four key investment areas are: transforming the biohealth paradigm, data-driven AI healthcare, strengthening essential and regional healthcare, and mission-oriented challenge-driven research.


In particular, for AI healthcare, the government will focus on securing high-quality bio and clinical data; establishing foundational AI healthcare systems; widespread deployment of medical AI; and nurturing convergence AI professionals. Strategic support will be provided for AI-based full-cycle drug development, novel modality development, advanced medical devices with strong global competitiveness, localization of essential medical devices, and development of next-generation regenerative medicine technologies. Efforts will also include connecting public clinical data for medical AI training, expanding foundational AI healthcare, and accelerating the adoption of AI in clinical settings.



Lee Hyunghoon, Second Vice Minister of Health and Welfare, stated, “National healthcare R&D is a core foundation that supports both the health of people and the competitiveness of the biohealth industry. By strategically fostering these top national technologies and systematically building a foundation for research data utilization, we will accelerate our drive to establish South Korea as a leading global biohealth nation.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing